Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Komoike

Showing results (171-180 of 184) with videos related to

Pageof 19
Sort By:
Anticancer Research|July 2, 2014
Phase II study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancerTsutomu Takashima, Takahiro Nakayama, Katsuhide Yoshidome, et al.
Genesis (New York, N.Y. : 2000)|February 11, 2010
Zebrafish gene knockdowns imply roles for human YWHAG in infantile spasms and cardiomegalyYuta Komoike, Katsunori Fujii, Akira Nishimura, et al.
Breast Cancer (Tokyo, Japan)|February 18, 2021
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort studyKiyo Tanaka, Norikazu Masuda, Naoki Hayashi, et al.
Breast Cancer Research and Treatment|September 13, 2020
The efficacy and safety of pertuzumab plus trastuzumab and docetaxel as a first-line therapy in Japanese patients with inoperable or recurrent HER2-positive breast cancer: the COMACHI studyMasato Takahashi, Shoichiro Ohtani, Shigenori E Nagai, et al.
International Journal of Oncology|May 26, 1999
Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinomaY Komoike, Y Tamaki, I Sakita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2023
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III TrialTakuji Iwase, Shigehira Saji, Kotaro Iijima, et al.
Case Reports in Gastroenterology|December 7, 2016
A Giant Gastrointestinal Stromal Tumor of the Stomach with Extramural GrowthRyosuke Miyazaki, Seiji Arihiro, Eri Hayashi, et al.
Cancers|September 10, 2021
Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214Norikazu Masuda, Tetsuhiro Yoshinami, Masahiko Ikeda, et al.
Nature Genetics|July 3, 2007
Germline gain-of-function mutations in RAF1 cause Noonan syndromeM Abdur Razzaque, Tsutomu Nishizawa, Yuta Komoike, et al.
Breast Cancer (Tokyo, Japan)|April 29, 2005
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumorsYoshifumi Komoike, Futoshi Akiyama, Yuichi Iino, et al.
Pageof 19

Showing results (171-180 of 184) with videos related to

Sort By:
Pageof 19
Anticancer Research|July 2, 2014
Phase II study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancerTsutomu Takashima, Takahiro Nakayama, Katsuhide Yoshidome, et al.
Genesis (New York, N.Y. : 2000)|February 11, 2010
Zebrafish gene knockdowns imply roles for human YWHAG in infantile spasms and cardiomegalyYuta Komoike, Katsunori Fujii, Akira Nishimura, et al.
Breast Cancer (Tokyo, Japan)|February 18, 2021
Clinicopathological predictors of postoperative upstaging to invasive ductal carcinoma (IDC) in patients preoperatively diagnosed with ductal carcinoma in situ (DCIS): a multi-institutional retrospective cohort studyKiyo Tanaka, Norikazu Masuda, Naoki Hayashi, et al.
Breast Cancer Research and Treatment|September 13, 2020
The efficacy and safety of pertuzumab plus trastuzumab and docetaxel as a first-line therapy in Japanese patients with inoperable or recurrent HER2-positive breast cancer: the COMACHI studyMasato Takahashi, Shoichiro Ohtani, Shigenori E Nagai, et al.
International Journal of Oncology|May 26, 1999
Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinomaY Komoike, Y Tamaki, I Sakita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2023
Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III TrialTakuji Iwase, Shigehira Saji, Kotaro Iijima, et al.
Case Reports in Gastroenterology|December 7, 2016
A Giant Gastrointestinal Stromal Tumor of the Stomach with Extramural GrowthRyosuke Miyazaki, Seiji Arihiro, Eri Hayashi, et al.
Cancers|September 10, 2021
Capecitabine in Combination with Endocrine Therapy as Maintenance Therapy after Bevacizumab Plus Paclitaxel Induction Therapy for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: KBCSG-TR1214Norikazu Masuda, Tetsuhiro Yoshinami, Masahiko Ikeda, et al.
Nature Genetics|July 3, 2007
Germline gain-of-function mutations in RAF1 cause Noonan syndromeM Abdur Razzaque, Tsutomu Nishizawa, Yuta Komoike, et al.
Breast Cancer (Tokyo, Japan)|April 29, 2005
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumorsYoshifumi Komoike, Futoshi Akiyama, Yuichi Iino, et al.
Pageof 19